Topiramate treatment of women with borderline personality disorder, part II: An open 18-month follow-up

Journal of Clinical Psychopharmacology

Volumn 28, Issue 3, 2008, Pages 355-357

  Loew, Thomas H ^a   Nickel, Marius K ^b,c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOPIRAMATE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

ADULT; BORDERLINE STATE; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DIZZINESS; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; OPEN STUDY; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; SOMNOLENCE; STRUCTURED INTERVIEW; TREATMENT RESPONSE; WEIGHT REDUCTION; ADOLESCENT; DOUBLE BLIND PROCEDURE;

ADOLESCENT; ADULT; ANTICONVULSANTS; BORDERLINE PERSONALITY DISORDER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS;

EID: 51449091835     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318173a8fb     Document Type: Letter

References (17)

1. Nickel M, Nickel C, Mitterlehner F, et al. Treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry. 2004;65:1515-1519.
2. Nickel M, Nickel C, Kaplan P, et al. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebocontrolled study. Biol Psychiatry. 2005;57: 495-499.
3. Nickel M, Muehlbacher M, Nickel C, et al. Aripiprazole in treatment of borderline patients: a double-blind, placebo-controlled study. Am J Psychiatry. 2006;163:833-838.
4. Zanarini MC. Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep. 2004;6:66-70.
5. Tritt K, Nickel C, Mitterlehner F, et al. Lamotrigine treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Psychopharmacol. 2005;19:287-291.
6. Loew T, Nickel M, Kaplan P, et al. Topiramate treatment of women with borderline personality disorder: a double-blind, placebocontrolled study. J Clin Psychopharmacol. 2006;26:61-66.
7. Schmidt do Prado-Lima PA, Bacaltchuck J. Topiramate in treatment-resistant depression and binge-eating disorder. Bipolar Disord. 2002;4:271-273.
8. Chong MS, Libretto SE. The rationale and use of topiramate in treating neuropathic pain. Clin J Pain. 2003;19:59-68.
9. Bozikas VP, Petrikis P, Kourtis A, et al. Treatment of acute mania with topiramate in hospitalized patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1203-1206.
10. Stahl SM. Anticonvulsants as anxiolytics, Part 1: Tiagabine and other anticonvulsants with actions on GABA. J Clin Psychiatry. 2004;65: 291-292.
11. Janowsky DS, Kraus JE, Barnhill J, et al. Effects of topiramate on aggressive, selfinjurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study. J Clin Psychopharmacol. 2003;23:500-504.
12. Rubio G, Jimenez-Arriero MA, Martinez-Gras I, et al. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder. J Clin Psychopharmacol. 2006;26:341-344.
13. Mc Intyre RS, Mancini DA, McCann S, et al. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord. 2002;4: 207-213.
14. Carpenter LL, Leon Z, Yasmin S, et al. Do obese depressed patients respond to topiramate? A retrospective chart review. J Affect Disord. 2002;69:251-255.
15. Nickel M, Nickel C, Muehlbacher M, et al. Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2005;25:211-217.
16. Kaplan M. Hypomania with topiramate. J Clin Psychpharmacol. 2005;25:196-197.
17. Teter CJ, Early JJ, Gibbs CM. Treatment of affective disorder and obesity with topiramate. Ann Pharmacother. 2000;34:1262-1268.